Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,980 | -88,098 | -68,101 | -46,342 | -23,678 |
| Depreciation Amortization | -385 | 1,850 | 1,859 | 1,458 | 823 |
| Other Working Capital | -6,611 | 2,768 | 2,481 | -3,087 | -2,392 |
| Other Operating Activity | 577 | 6,976 | 5,209 | 2,870 | 933 |
| Operating Cash Flow | $-23,399 | $-76,504 | $-58,552 | $-45,101 | $-24,314 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,994 | 59,815 | 43,196 | 41,011 | 41,450 |
| PPE Investments | -3 | -1,953 | -1,769 | -1,034 | -605 |
| Investing Cash Flow | $28,991 | $57,862 | $41,427 | $39,977 | $40,845 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 503 | 359 | 359 | 107 |
| Financing Cash Flow | $N/A | $503 | $359 | $359 | $107 |
| Beginning Cash Position | 10,809 | 28,948 | 28,948 | 28,948 | 28,948 |
| End Cash Position | 16,401 | 10,809 | 12,182 | 24,183 | 45,586 |
| Net Cash Flow | $5,592 | $-18,139 | $-16,766 | $-4,765 | $16,638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,399 | -76,504 | -58,552 | -45,101 | -24,314 |
| Capital Expenditure | -3 | -1,953 | -1,769 | -1,034 | -605 |
| Free Cash Flow | -23,402 | -78,457 | -60,321 | -46,135 | -24,919 |